Abstract
BACKGROUND: Recent developments in molecular genetics have made it possible to identify carriers of the cystic fibrosis (CF) mutation, regardless of family history, before they have an affected child. Using these techniques, population or 'community' carrier screening can offer informed reproductive choice to individuals and couples who would not otherwise know of their risk of having a CF child. AIM: This study set out to assess the views of general practitioners (GPs) on community carrier screening for CF and to consider the factors that influence their willingness to offer it themselves. METHOD: A self-administered questionnaires was sent to all 616 GPs in four areas of North Thames (West) Region. RESULTS: Two-thirds of respondents indicated that identifying carrier couples to offer genetic counselling before conception was a very important benefit of community carrier screening. Two-thirds felt that general practice was the most appropriate place in which to offer it, and similar proportions that the most appropriate times to do so were when a close relative was diagnosed and when seeking family planning. About half wanted to offer community carrier screening themselves; this was related to experience with CF patients and CF carrier testing, and estimates of the numbers of CF carriers in the practice. CONCLUSIONS: There is considerable support among GPs for community carrier screening for CF in general practice, particularly in the context of family planning services. Knowledge and experience of CF increase GPs' willingness to offer it themselves.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bekker H., Modell M., Denniss G., Silver A., Mathew C., Bobrow M., Marteau T. Uptake of cystic fibrosis testing in primary care: supply push or demand pull? BMJ. 1993 Jun 12;306(6892):1584–1586. doi: 10.1136/bmj.306.6892.1584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burn J. Screening for cystic fibrosis in primary care. BMJ. 1993 Jun 12;306(6892):1558–1559. doi: 10.1136/bmj.306.6892.1558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dodge J. A. Implications of the new genetics for screening for cystic fibrosis. Lancet. 1988 Sep 17;2(8612):672–674. doi: 10.1016/s0140-6736(88)90479-5. [DOI] [PubMed] [Google Scholar]
- Harris H., Scotcher D., Hartley N., Wallace A., Craufurd D., Harris R. Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ. 1993 Jun 12;306(6892):1580–1583. doi: 10.1136/bmj.306.6892.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Livingstone J., Axton R. A., Gilfillan A., Mennie M., Compton M., Liston W. A., Calder A. A., Gordon A. J., Brock D. J. Antenatal screening for cystic fibrosis: a trial of the couple model. BMJ. 1994 Jun 4;308(6942):1459–1462. doi: 10.1136/bmj.308.6942.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Magnay D., Wilson O., el Hait S., Balhamar M., Burn J. Carrier testing for cystic fibrosis: knowledge and attitudes within a local community. J R Coll Physicians Lond. 1992 Jan;26(1):69–70. [PMC free article] [PubMed] [Google Scholar]
- Mennie M. E., Gilfillan A., Compton M., Curtis L., Liston W. A., Pullen I., Whyte D. A., Brock D. J. Prenatal screening for cystic fibrosis. Lancet. 1992 Jul 25;340(8813):214–216. doi: 10.1016/0140-6736(92)90476-j. [DOI] [PubMed] [Google Scholar]
- Miedzybrodzka Z. H., Hall M. H., Mollison J., Templeton A., Russell I. T., Dean J. C., Kelly K. F., Marteau T. M., Haites N. E. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. BMJ. 1995 Feb 11;310(6976):353–357. doi: 10.1136/bmj.310.6976.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitchell J., Scriver C. R., Clow C. L., Kaplan F. What young people think and do when the option for cystic fibrosis carrier testing is available. J Med Genet. 1993 Jul;30(7):538–542. doi: 10.1136/jmg.30.7.538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Modell B. Cystic fibrosis screening and community genetics. J Med Genet. 1990 Aug;27(8):475–479. doi: 10.1136/jmg.27.8.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Modell M. Screening for carriers of cystic fibrosis--a general practitioner's perspective. BMJ. 1993 Oct 2;307(6908):849–852. doi: 10.1136/bmj.307.6908.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qureshi N., Raeburn J. A. Clinical genetics meets primary care. BMJ. 1993 Oct 2;307(6908):816–817. doi: 10.1136/bmj.307.6908.816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ranieri E., Ryall R. G., Morris C. P., Nelson P. V., Carey W. F., Pollard A. C., Robertson E. F. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. BMJ. 1991 May 25;302(6787):1237–1240. doi: 10.1136/bmj.302.6787.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
- Watson E. K., Mayall E., Chapple J., Dalziel M., Harrington K., Williams C., Williamson R. Screening for carriers of cystic fibrosis through primary health care services. BMJ. 1991 Aug 31;303(6801):504–507. doi: 10.1136/bmj.303.6801.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watson E. K., Williamson R., Chapple J. Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public. Br J Gen Pract. 1991 Jun;41(347):237–240. [PMC free article] [PubMed] [Google Scholar]
- Williamson R., Allison M. E., Bentley T. J., Lim S. M., Watson E., Chapple J., Adam S., Boulton M. Community attitudes to cystic fibrosis carrier testing in England: a pilot study. Prenat Diagn. 1989 Oct;9(10):727–734. doi: 10.1002/pd.1970091008. [DOI] [PubMed] [Google Scholar]
- Williamson R. Universal community carrier screening for cystic fibrosis? Nat Genet. 1993 Mar;3(3):195–201. doi: 10.1038/ng0393-195. [DOI] [PubMed] [Google Scholar]